Trial to Optimize Patients Selection for Endovascular Treatment in Acute Ischemic Stroke

  • STATUS
    Recruiting
  • participants needed
    20
Send
Updated on 19 February 2024

Summary

Stroke can occur when a clot stops the flow of the blood in one of the arteries supplying the brain. This type of stroke, called ischemic stroke, can be treated alone or in a combination of drugs to dissolve the clot, devices to remove the clot (mechanical thrombectomy) or use of treatments to prevent the stroke from happening again or help you get better after having a stroke. Use of devices to remove the clot (mechanical thrombectomy) has been shown to improve outcomes in patients with a clot in one of the large arteries of the brain. However, not all patients with a clot in one of the large arteries are treated with these devices. To select the patients for such device treatment, physicians usually rely on various information including time from onset of the stroke, patient’s age and how much care a patient can take of himself/herself without additional assistance before the stroke. They also rely on computer-generated images of a patient’s brain obtained by x-rays (Computed Tomography (CT) scan) or magnetic field (Magnetic Resonance Imaging – MRI). Sometimes, the physicians also get images that provide information about blood flow to the brain (perfusion imaging). However, these studies take more time and are not always available. The study wants to examine if images obtained by CT scan can identify patients for thrombectomy just as efficiently as perfusion imaging.
 
Additionally, this study aims to evaluate if mechanical thrombectomy plus medical management is better than medical management alone in patients who have a large stroke. It is currently unclear if mechanical thrombectomy plus medical management compared to medical management alone will lead to a better recovery from stroke in patients who have a large stroke.  For this study, medical management may include medications, such as aspirin, intravenous fluids, stopping blood pressure lowering medications, and close neurologic monitoring.

Description


FAQ


Details
Condition stroke
Age 99years or below
Clinical Study IdentifierTX6463
Last Modified on19 February 2024

Eligibility

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.